These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21466616)

  • 1. Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
    Handelsman Y
    J Clin Hypertens (Greenwich); 2011 Apr; 13(4):221-3. PubMed ID: 21466616
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension and the kidney.
    Wiederkehr M; Toto R; Fenves AZ; Ram CV
    Semin Nephrol; 2005 Jul; 25(4):236-45. PubMed ID: 16202696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
    J Hypertens Suppl; 1992 Apr; 10(1):S1-53. PubMed ID: 1619498
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular and renal disease in untreated and treated hypertension.
    Mancia G; Giannattasio C; Pozzi M
    Contrib Nephrol; 1994; 109():65-9. PubMed ID: 7956231
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.
    Gorr MW; Wold LE
    Curr Opin Pharmacol; 2020 Oct; 54():vii-ix. PubMed ID: 33357715
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrology and hypertension].
    Mogensen CE
    Journ Annu Diabetol Hotel Dieu; 2003; ():261-77. PubMed ID: 12868315
    [No Abstract]   [Full Text] [Related]  

  • 7. [What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension].
    Eguchi K; Kario K; Shimada K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():679-84. PubMed ID: 12387069
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
    Chen J; Townsend RR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based treatment of hypertension in patients with type 2 diabetes.
    De Vriese A
    Acta Clin Belg; 2001; 56(2):96-102. PubMed ID: 11383319
    [No Abstract]   [Full Text] [Related]  

  • 11. The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
    Ruilope L; Kjeldsen SE; de la Sierra A; Mancia G; Ruggenenti P; Stergiou GS; Bakris GL; Giles TD
    Blood Press; 2007; 16(2):72-9. PubMed ID: 17612904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
    Flaa A; Aksnes TA; Strand A; Kjeldsen SE
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):451-61. PubMed ID: 17489670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
    Tislér A
    Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARBs for cardiovascular and renal protection in high-risk patients.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 2 Diabetes.
    Vijan S
    Ann Intern Med; 2019 Nov; 171(9):ITC65-ITC80. PubMed ID: 31683294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is activated vitamin D supplementation renoprotective?
    Weir MR
    Hypertension; 2008 Aug; 52(2):211-2. PubMed ID: 18606899
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract]   [Full Text] [Related]  

  • 19. Aggressively preventing diabetes.
    Schrier RW
    Nat Rev Nephrol; 2010 Jun; 6(6):313. PubMed ID: 20508667
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.